Aviva’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,083
Closed -$1.49M 1007
2022
Q3
$1.49M Sell
18,083
-1,950
-10% -$192K 0.01% 807
2022
Q2
$2.2M Sell
20,033
-3,614
-15% -$358K 0.01% 750
2022
Q1
$2.25M Buy
23,647
+522
+2% +$50.6K 0.01% 795
2021
Q4
$2.61M Buy
+23,125
New +$2.51M 0.01% 770
2021
Q2
Sell
-11,732
Closed -$1.2M 898
2021
Q1
$1.2M Sell
11,732
-3,372
-22% -$336K 0.01% 842
2020
Q4
$1.31M Sell
15,104
-12,247
-45% -$1.14M 0.01% 813
2020
Q3
$2.47M Sell
27,351
-6,803
-20% -$544K 0.01% 601
2020
Q2
$2.29M Sell
34,154
-35,024
-51% -$2.25M 0.01% 703
2020
Q1
$3.82M Buy
69,178
+42,886
+163% +$2.92M 0.03% 484
2019
Q4
$1.99M Buy
+26,292
New +$1.99M 0.01% 721

Other funds holding DORM

Aviva's DORM Position: Q4 2022 in Review

Aviva sold out of Dorman Products (DORM) in Q4 2022, closing a stake of 18,083 shares — an estimated $1.49M sold.

Aviva first reported a position in DORM in Q4 2019 and held it in 10 quarters. The position peaked at $3.82M in Q1 2020. 241 funds tracked by Wall St. Rank hold DORM as of Q4 2022.

  • Aviva reported no remaining Dorman Products position as of Q4 2022 after selling out during the quarter.
  • Aviva sold 18,083 Dorman Products shares in Q4 2022, an estimated $1.49M.
  • Aviva first reported a position in Dorman Products in Q4 2019 and held it in 10 quarters.
  • Aviva's Dorman Products position peaked at $3.82M in Q1 2020.
  • 241 funds tracked by Wall St. Rank held Dorman Products as of Q4 2022.

Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.